BGAM
STJ

Boussard & Gavaudan Asset Management’s St Jude Medical STJ Stock Holding History

Boussard & Gavaudan Asset Management’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,616
Closed -$251K – 99
2014
Q2 		$251K Sell
3,616
-22
-0.6% -$1.43K 0.13% 55
2014
Q1 		$237K Sell
3,638
-205
-5% -$13.3K 0.15% 56
2013
Q4 		$238K Buy
+3,843
New +$223K 0.17% 41

Other funds holding STJ

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 30.2% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Boussard & Gavaudan Asset Management's STJ Position: Q3 2014 in Review

Boussard & Gavaudan Asset Management sold out of St Jude Medical (STJ) in Q3 2014, closing a stake of 3,616 shares — an estimated $251K sold.

Boussard & Gavaudan Asset Management first reported a position in STJ in Q4 2013 and held it in 3 quarters. The position peaked at $251K in Q2 2014. 563 funds tracked by Wall St. Rank hold STJ as of Q3 2014.

  • Boussard & Gavaudan Asset Management reported no remaining St Jude Medical position as of Q3 2014 after selling out during the quarter.
  • Boussard & Gavaudan Asset Management sold 3,616 St Jude Medical shares in Q3 2014, an estimated $251K.
  • Boussard & Gavaudan Asset Management first reported a position in St Jude Medical in Q4 2013 and held it in 3 quarters.
  • Boussard & Gavaudan Asset Management's St Jude Medical position peaked at $251K in Q2 2014.
  • 563 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2014.

Based on Boussard & Gavaudan Asset Management's 13F filing for Q3 2014.